Related Experiment Video
Updated: Jul 3, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Variability of hepatitis B testing in British Columbian ESRD patients: the case to focus on implementation of
Monica Beaulieu1, Mel Krajden, Jane Buxton
1Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada. monicabe@interchange.ubc.ca
Insights
Hepatitis B virus (HBV) retesting in dialysis patients shows significant practice variations. Only 50% receive appropriate monitoring, indicating a need for standardized protocols to improve care and reduce costs.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- Hepatitis B virus (HBV) immunization is standard in dialysis units.
- Follow-up testing and booster dose recommendations for HBV in dialysis patients lack standardization.
Purpose of the Study:
- To describe HBV testing variations in British Columbia dialysis centers.
- To propose an evidence-based HBV follow-up testing protocol.
- To compare current practices with the proposed protocol.
Main Methods:
- Quality improvement report analyzing a provincial dialysis cohort (n=1,055).
- Data collected on HBV test frequency by center and dialysis modality.
- Guidelines were reviewed to develop a standardized protocol.
Main Results:
- Significant variations in HBV testing frequency were observed across centers and dialysis types (P < 0.001).
- Only 50% of patients received recommended HBV retesting; 37% were tested excessively.
- Hemodialysis and HBV-infected patients were tested more frequently than recommended.
Conclusions:
- Current HBV retesting practices in dialysis patients are inconsistent, with 50% adherence to an evidence-based protocol.
- Over-testing occurs in hemodialysis and HBV-infected patients, suggesting potential cost savings through protocol adherence.
- Implementing a standardized protocol is crucial for appropriate patient monitoring and resource optimization.
Background:
Hepatitis B virus (HBV) immunization protocols are routinely followed in dialysis units. Recommendations for retesting and booster dose administration are variable and less well known.
Design:
Quality improvement report.
Setting & Participants:
Provincial dialysis cohort in all 5 regional centers in British Columbia (n = 1,055).
Quality Improvement Plan:
(1) Describe the variations in HBV testing practice patterns between centers and modalities of dialysis, (2) propose an evidence-based protocol for HBV follow-up testing, and (3) compare the current practice for HBV follow-up testing with the protocol.
Measures:
(1) Number of HBV tests performed based on geographic center and dialysis modality; (2) tabulation of local, national, and international guidelines to determine concordance and develop British Columbian protocol, and (3) percentage of patients who received recommended HBV testing based on protocol.
Results:
(1) Significant variation noted in HBV testing frequency among the 5 regional centers and between hemodialysis and peritoneal dialysis patients (P < 0.001); (2) current available guidelines generally are concordant, but vary in regard to frequency of follow-up testing; and (3) comparing recommended testing frequency with actual testing, 50% of patients were tested as recommended; 13%, less than recommended; and 37%, more than recommended. Hemodialysis patients often were tested more than recommended (hemodialysis, 47% versus peritoneal dialysis, 16%; P < 0.01). Patients with current or past HBV infection were tested more than recommended (P < 0.01). All variability remained significant when adjusted for age, sex, and dialysis therapy duration in a multivariate model.
Limitations:
The cohort was ascertained from laboratory data; therefore, information for vaccination and booster dose administration was not available.
Conclusion:
In a cohort of dialysis patients initially screened for hepatitis B, 50% of patients are being appropriately monitored with retesting compared with an evidence-based protocol. Patients with known HBV infection and hemodialysis patients are being tested more than recommended. Adherence to a protocol for retesting would ensure appropriate follow-up and reduce unnecessary retesting, potentially leading to significant cost savings.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Methods of Documentation V: CBE
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
Viral Hepatitis I: Introduction
